Kiora Pharmaceuticals earnings were -$11.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest KPRX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.1M, down 14% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KPRX reported annual earnings of -$10.8M, with -401.4% growth. The next KPRX earnings date is Nov 6, 2026.
Kiora Pharmaceuticals Earnings Reports & History FAQ
What were Kiora Pharmaceuticals's earnings last quarter?
On KPRX's earnings call on Aug 14, 2026, Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q2 2026 earnings per share (EPS) of -$0.34, up 37.04% year over year. Total KPRX earnings for the quarter were -$2.08 million. In the same quarter last year, Kiora Pharmaceuticals's earnings per share (EPS) was -$0.54.
The next KPRX earnings date is Nov 6, 2026. Add KPRX to your watchlist to be reminded of Kiora Pharmaceuticals's next earnings date.
What was KPRX's earnings growth in the past year?
As of Kiora Pharmaceuticals's earnings date in Aug 14, 2026, Kiora Pharmaceuticals's earnings has grown year over year. KPRX earnings in the past year totalled -$10.99 million.
Is Kiora Pharmaceuticals profitable or losing money?
As of the last Kiora Pharmaceuticals earnings report, Kiora Pharmaceuticals is currently losing money. Kiora Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$10.99 million, a 8.31% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.